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ABSTRACT
Mitochondrial respiratory chain defects have
been associated with various diseases and normal
aging, particularly in tissues with high energy
demands including skeletal muscle. Muscle-
specific mitochondrial DNA (mtDNA) mutations
have also been reported to accumulate with aging.
Our understanding of the molecular processes
mediating altered mitochondrial gene expression
to dysfunction associated with mtDNA mutations
in muscle would be greatly enhanced by our ability
to transfer muscle mtDNA to established cell lines.
Here, we report the successful generation of mouse
cybrids carrying skeletal muscle mtDNA. Using this
novel approach, we performed bioenergetic analysis
of cells bearing mtDNA derived from young and old
mouse skeletal muscles. A significant decrease in
oxidative phosphorylation coupling and regulation
capacity has been observed with cybrids carrying
mtDNA from skeletal muscle of old mice. Our
results also revealed decrease growth capacity
and cell viability associated with the mtDNA
derived from muscle of old mice. These findings
indicate that a decline in mitochondrial function
associated with compromised mtDNA quality
during aging leads to a decrease in both the
capacity and regulation of oxidative phos-
phorylation.
INTRODUCTION
Mitochondria are ubiquitous organelles in eukaryotic cells
whose primary function is to generate energy through
oxidative phosphorylation (1), the step-wise transfer of
electrons to oxygen coupled with ATP production.
High-energy electrons, which leave the electron transport
chain (ETC) prematurely, generate reactive oxygen species
(ROS) (2). Disruption of ETC has been suggested to alter
the production of ROS (3). Oxidative damage caused by
ROS to DNA, proteins and lipids in animal tissues has
been reported, and the quantity of such damage increases
during aging (4,5).
Skeletal muscles, which contain long ﬁbers formed from
a large number of fused cells, support or move the
skeleton. The performance of skeletal muscle, speed
and strength, deteriorates with aging due to ﬁber loss
and atrophy (6), a condition known as sarcopenia.
Cytochrome c oxidase (COX), the terminal component
of ETC, -negative muscle ﬁbers have been detected in
human, monkey, mouse and Drosophila, and their
quantity increases with age (7). In addition, studies
carried out with diﬀerent ages of rhesus monkeys
indicate regions of muscle ﬁbers exhibiting high levels of
ETC defects also contain a large accumulation of mtDNA
deletions (8). Further, mtDNA deletions in old animals
could focally accumulate to high levels in certain muscle
ﬁbers, and that could directly contribute to sarcopenia
(9,10). Interestingly, in calorie-restricted mice, a
consistently proven animal model of extended mean and
maximum life span and attenuated development of
age-related diseases (11,12), both the accumulation of
deleted mtDNAs and the number of COX-negative
ﬁbers, were decreased (13).
Mitochondrial function is under dual genome control.
Although the majority of structural genes and all of the
regulatory genes are encoded by the nuclear genome, the
mitochondrial genome contains the sequences for 37
genes, including 13 for essential polypeptides of the
oxidative phosphorylation apparatus, 22 tRNAs and
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is believed that since mtDNA is close to the ROS gener-
ation site, it undergoes relatively more cycles of replication
(especially in postmitotic cells such as muscles), and is
subject to a reduced breadth of DNA repair activities.
Consistent with this hypothesis, mtDNA exhibits a rela-
tively high mutation frequency (16).
The successful development of mitochondrial-mediated
transformation has opened the way to elucidate the role of
mtDNA (17). However, in-depth studies of the contribu-
tions of mtDNA mutations to tissue-speciﬁc pathogenesis
are limited as the transfer of mitochondria from tissues
to cell lines has only successfully been carried out with
platelets (18) and synaptosomes (19,20). A noticeable
missing technique is a method to establish cybrids with
mtDNA derived from muscle. In the present study, we
developed a new approach to generate cybrids containing
mtDNA from mouse skeletal muscle. Using this method,
we further analyzed respiratory activity and growth
capacity in glucose and galactose media of cybrids with
mtDNA from old and young mice.
MATERIALS AND METHODS
Animals and sample preparation
C57BL/6 and DBA/2 mice were purchased from Charles
River Laboratories. Among them, six each of C57BL/6
were aged to 6 and 26 months at the UTHSCSA animal
facility. Skeletal muscles were dissected from the hind legs.
Each muscle was cut into small pieces on a 10-mm dish on
ice, and rinsed several times with Hank’s Balanced Salt
Solution (HBSS, Invitrogen). The muscle samples were
resuspended with 6vol hypotonic buﬀer (RSB) (10.0mM
Tris,10.0mM KCl, 0.15mM MgCl2, pH 6.7) and further
processed with a Dounce A type homogenizer for about
30 strokes. The processed samples were then centrifuged at
2300r.p.m. for 3min and the supernatant was then sub-
jected to another centrifugation at 1000r.p.m. for 10min.
Finally, muscle mitochondria enclosed by plasma
membrane were collected by centrifugation at
6500r.p.m. for 10min.
Cell lines and media
All cell lines used in the present work were grown in
monolayer culture. The mtDNA-less r
0 LL/2-m21 cell
line was a derivative of mouse cell line LL/2 as described
previously (21). Cells were grown in Dulbecco’s Modiﬁed
Eagle Medium (DMEM) supplemented with 10% fetal
bovine serum (FBS).
mtDNA analysis
For mtDNA sequencing, total DNA was extracted with
the Easy-DNA
TM kit (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer’s instructions, and then
subjected to polymerase chain reaction (PCR) ampliﬁca-
tion of the fragments containing part of the tRNA
Arg and
ND3 genes. Ampliﬁed mtDNA fragments were puriﬁed
using the AllStar PCR Clean Up kit (AllStar Sci. Inc.,
Sunnyvale, CA, USA), and puriﬁed PCR products were
sequenced.




The measurements were carried out in two chambers of a
YSI Model 5300 Biological Oxygen Monitor as described
earlier (22). Brieﬂy, determination of the O2 consumption
rate was carried out in about 510
6 cells in Tris-based,
Mg
2+,C a
2+-deﬁcient (TD) buﬀer (0.137M NaCl, 5mM
KCl, 0.7mM Na2HPO4, 25mM Tris–HCl, pH 7.4). After
recording the base respiration rate, 2.5mg/ml oligomycin
was added to measure uncoupled respiration, and then
0.5mM FCCP was added to determine maximal
respiration.
Cell growth and viability analysis
Multiple identical samples of 510
4 cells were grown for 4
days on six-well plates in the appropriate medium
(DMEM, which contains 4.5mg/ml glucose and 0.11mg/
ml pyruvate, or DMEM lacking glucose and containing
0.9mg/ml galactose and 0.11mg/ml pyruvate, both sup-
plemented with 10% dialyzed FBS), and counted on a
daily basis. Doubling time=72hLn (2)/[Ln (total cell
number at 96h)-Ln (total cell number at 24h)].
Cell viability was analyzed with a Vi-Cell
TM XR cell
viability analyzer (Beckman Coulter).
mtDNA content analysis
The relative mtDNA levels were measured by a real-time
PCR and normalized by simultaneous measurement of
the nuclear DNA. Primers and probes for quantitative
PCR (qPCR) were designed using Primer Express
(Applied Biosystems). QPCR was carried out using an
ABI 7900HT Fast Real-Time PCR System (Applied
Biosystems) in 20-ml reaction in diﬀerent tubes containing
0.5mM each of the forward and reverse primers, 0.1mM
for each probe (ND3 and b-actin genes) and 50ng DNA
sample. The PCR conditions were 95C for 15min,
followed by 40 cycles of 95C for 15s, and 60C for 60s.
The threshold cycle number (Ct) values of the b-actin gene
and the mitochondrial ND3 gene were determined. Each
measurement was carried out four times and normalized
against a serial dilution of a control DNA sample. Ct
values can be used as a measure of the input DNA
contents and Ct value diﬀerences were used to quantify
mtDNA levels relative to the b-actin gene with the follow-
ing equation: Relative copy number (Rc)=2
Ct, where
Ct is the Ctb-actinCtND3
The primer and probe information is as follows:
For mtDNA ND3: forward, TCTGACTCCCCCAAA
TAAATCTG; reverse, GGGTCGAATCCGCATTCA.
For nuclear b-actin: forward, AAATCGTGCGTGAC
ATCAAAGA; reverse, GGCCATCTCCCTGCTCGAA.
Probes: Cox III, FAM- TCAGAAAAAGCAAATCC;
b-actin, FAM- AGCTGTGCTATGTTGCT.
1914 Nucleic Acids Research, 2010,Vol.38, No. 6Statistical analysis
P, probability, values were calculated by using the
unpaired Student’s t-test contained in the Microsoft
Excel program. The diﬀerence is considered as statistically
signiﬁcant when P<0.05. r, Pearson product-moment
correlation coeﬃcient, is a measure of the strength of
linear dependence between two variables. It ranges from
1 to 1. A value of 1 implies that a linear equation
describes the relationship perfectly; a value of 1 implies
a perfect negative correlation; a value of 0 implies that
there is no linear correlation between the variables.
RESULTS
Generation of cybrids with mitochondria from mouse
skeletal muscle
As shown in Figure 1, muscle samples were obtained from
hind legs of healthy mice right after the animals were
euthanized. In particular, muscles were dissected out;
fatty and nerve cells were removed. After being rinsed
with HBSS, the muscle samples were cut into small
pieces on ice. Fine muscle pieces were subjected to treat-
ment with hypotonic buﬀer and then homogenized.
The processed muscle was constantly checked under the
Figure 1. Generation of cybrids containing mtDNA from skeletal muscle. Flowchart of how mtDNA from the skeletal muscle was transferred to r
0
cells to produce cybrids.
Nucleic Acids Research,2010, Vol.38, No. 6 1915microscope after 20 strokes with the homogenizer until the
nuclei were released and plasma membrane-enclosed
mitochondria formed. The processed samples were then
centrifuged at 2300r.p.m. for 3min and the supernatant
was then subjected to another centrifugation at
1000r.p.m. for 10min. Finally, muscle mitochondria
enclosed by plasma membrane were collected by
centrifugation at 6500r.p.m. for 10min.
Fusion solution was prepared as 9g of polyethylene
glycol (PEG) (Sigma P-5402; MW: 1450) was autoclaved
with slow exhaust for 15min, and then 2ml DMSO and
9ml DMEM were added when it was cooled to about
65C. The solution was mixed gently and then kept in
37C incubator. The mouse mtDNA-less LL/2-m21 r
0
cell line was established previously (23). Approximately
10
6 r
0 cells were mixed with freshly isolated membrane
enclosed muscle mitochondria prepared from about 1g
of muscle sample from two hind legs. The mixture was
centrifuged for 10min at 2000g, and the pellet was
resuspended with 45% PEG by mild and brief pipetting
while avoiding the creation of air bubbles. After one-min
treatment with PEG, the fusion process was stopped by
diluting with 10 volumes of DMEM. The fusion products
were incubated with DMEM supplemented with 50mg/ml
uridine at 37C for 24h. On Day 2, the medium was
replaced by semi-selection media with the amount of
uridine reduced to10mg/ml. Five days later, the medium
was changed again to selection medium, i.e. the same
medium without uridine. Transformants were selected
based on the pyrimidine auxotrophy of the r
0 cells (24)
as the cybrids containing exogenous mitochondria from
muscle were able to survive in the selective medium.
Validation of the transfer of mtDNA from muscle to
cybrids
To conﬁrm that the cybrids we generated did carry the
mtDNA from the speciﬁc muscle tissues, we did a pilot
experiment utilizing two species of mice, C57BL/6 and
DBA/2, with distinctive mtDNA sequences. Six clones
each were selected from the fusion of C57BL/6 and
DBA/2 skeletal muscle to LL/2-m21 r
0 cells. As two
sequencing variances between C57BL/6 and DBA/2 have
been identiﬁed in the ND3 and tRNA
Arg genes (25,26), we
determined the sequence of two DNA fragments covering
these genes in the putative transmitochondrial clones con-
taining the mtDNA from the muscle (Figure 2B and D).
The mtDNA from the original muscle samples was also
sequenced as a control (Figure 2A and C). Representative
sequencing results are shown in Figure 2. As indicated by
the signature sequences at positions 9461 and 9818 (25,26),
the clones derived from the fusion products of muscle
from DBA/2 carried a C at position 9461, and were with
a stretch of 9A from position 9821 to 9829; while clones
from C57BL/6 muscle exhibited a T at position 9461 and
were with 8A from position 9821 to 9828; both matched
the mtDNA from the original muscle samples, respec-
tively. It is interesting to note that the DBA/2 mice in
this study were heteroplasmic at 9821 with about 10%
carrying 10A (Figure 2A), and the heteroplasmy was lost
during mitochondria-mediated transformation as
observed previously (21). Thus, our fusion approach has
been validated.
Production of cybrids with muscle mtDNA from mice
of diﬀerent ages
C57BL/6 mice at the age of 26 months (old) and 6 months
(young), six per group, were selected to investigate poten-
tial age-associated mtDNA alterations. Using the novel
method described herein, we have thus obtained 24 and
25 cybrid clones carrying mtDNA derived from the
skeletal muscles from young and old mice, respectively.
Respiration properties of trans-mitochondrial clones
To assess the mitochondrial function of the cybrids
carrying mtDNA from muscles of young and old mice,
the respiration properties were investigated. First, we
measured the endogenous respiration activity of intact
cells. As shown in Figure 3A, there was a decrease in
average base endogenous respiration in cybrids of old
groups compared with that of young group. We then
quantiﬁed oxygen consumption in the presence of
oligomycin A, a chemical inhibitor that can block
adenosine triphosphate (ATP)-synthase, or in the
presence of the chemical uncoupler FCCP, which can
completely uncouple oxidation from phosphorylation in
mitochondria and raise the respiratory capacity to a
maximal level. The diﬀerence between two age groups
was more pronounced (P<0.01) in the maximal respira-
tory capacity as revealed by oxygen consumption with
FCCP (Figure 3C). However, no signiﬁcant diﬀerences
in uncoupled respiration were detected when ATP
synthase was inhibited (Figure 3B).
To more carefully examine how respiration is coupled
with ATP synthesis in these cybrids, we then calculated the
ratio of oligomycin resistant to base endogenous respira-
tion. Compared with the young group, the average of the
old group exhibited a higher value (Figure 3D), indicating
more relaxed coupling of oxidative phosphorylation
associated with mtDNA from old mice. The capacity
of regulation over oxidative phosphorylation was also
monitored by calculating the ratio of FCCP-uncoupled
to oligomycin-resistant respiration. As shown in
Figure 3E, cybrids containing mtDNA from the old
group exhibited a lower average value, suggesting com-
promised control of mitochondrial membrane potential
over respiration associated with mtDNA from muscle
cells of old mice.
Growth and viability analysis
Mammalian cells rely on both mitochondrial oxidative
phosphorylation and glycolysis to generate ATP to
support various cellular pathways. However, they cannot
utilize galactose eﬃciently in the glycolytic pathway (27).
Figure 4 shows the study of growth properties of the
cybrids in glucose- and galactose-containing media. As
observed with respiratory activities, measurements of pop-
ulation doubling times revealed substantial variances
among the same age group. Nevertheless, overall, a signif-
icant diﬀerence between old and young groups was
1916 Nucleic Acids Research, 2010,Vol.38, No. 6observed. In particular, in regular glucose medium there
was no signiﬁcant diﬀerence in the average doubling time
between cells derived from the young and old groups
(Figure 4A). However, in the galactose medium, where
ATP production predominantly relies on mitochondrial
oxidative phosphorylation, the average doubling time of
old group cells was markedly longer than that of young
group cells (Figure 4B). In order to reduce the background
variability caused by other factors, the ratio of doubling
time in galactose medium to that in glucose medium was
calculated as indicated by the growth index. As shown in
Figure 4C, the diﬀerence between the two age groups per-
sisted, although with somewhat reduced statistical signif-
icance (P<0.05 versus P<0.01).
Figure 2. Validation of transfer of mtDNA from muscle to cybrids. Representative chromatograms of signature sequences of mtDNA at positions
9461 and 9818 and surrounding areas of DBA/2-muscle sample (A), cybrids derived from fusion of mitochondria from DBA/2 muscle and r
0 cells
(B), C57BL/6-muscle (C) and cybrids derived from fusion of mitochondria from C57BL/6 muscle and r
0 cells (D). An arrow shows the base
diﬀerence at 9461, and the diﬀerent lengths of the A-stretch are also indicated.
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with apoptosis, we further investigated cell viability in
glucose- and galactose-containing media following 3
days of culturing in the respective media. As shown in
Figure 5A, in the regular glucose medium, there was no
signiﬁcant diﬀerence in cell viability between the young
group and the old group. However, in the galactose
medium, the cell viability of the old group was
signiﬁcantly lower than that of the young group
(P<0.05) (Figure 5B). The ratio of viability in galactose
to that in glucose medium, indicated as viability index,
was signiﬁcantly lower for the old group relative to the
young group cells (P<0.05) (Figure 5C).
mtDNA content alteration and its implication
To investigate the alteration of mtDNA content as a result
of changes in mtDNA sequences associated with replica-
tion or turnover, the mtDNA copy number of the
transformants was measured by quantitative real- time
PCR method. While a considerable variability among
the clones derived from the same age group was
revealed, there is a clear tendency of decrease of
mtDNA content in the cybrids from old mice
(Figure 6A). To further determine if the decrease in
mtDNA copy number has any eﬀects on the compromised
mitochondrial function we observed, we plotted the
Figure 3. Oxygen consumption measurement. Six and 26 months represent 24 and 22 cybrids per age group, respectively. Endogenous respiration
was measured in intact cells (A), after treatment with the ATP synthase inhibitor oligomycin at 2.5mg/ml (B), and with the uncoupler FCCP at
0.5mM( C). The activities were determined with about 510
6 cells. Three determinations were made for each cybrid and the average values are
shown. Ratios of oligomycin-resistant to native endogenous respiration rates (D) and FCCP-treated fully uncoupled to oligomycin-resistant respi-
ration rates (E) of each age group were also calculated.
Figure 4. Growth capacity measurement. Six and 26 months represent 24 and 25 cybrids per age group, respectively. Cells were grown in
glucose-containing DMEM for 24h, then in glucose medium (A) or in galactose medium (B) for another 72h. Doubling times were calculated
as: 72hLog (2)/[Log (total cell number at the end)-Log (total cell number when media were changed)]. Three determinations were made for each
cybrid. Growth index was calculated as the ratio of doubling time in galactose-containing medium to that in glucose medium (C).
1918 Nucleic Acids Research, 2010,Vol.38, No. 6maximal respiration rate measured by oxygen consump-
tion with FCCP treatment (Figure 6B), growth index as
deﬁned by the ratio of doubling time of cybrids in
galactose medium to that in glucose medium (Figure 6C)
and cell viability index as the ratio of cell viability assayed
in galactose medium to that in glucose medium (Figure
6D), to mtDNA copy number, respectively. We found that
the maximal respiration rate declined as the mtDNA copy
number reduced (Figure 6B). Similarly, the normalized
growth capacity in galactose medium also reduced with
the decline of the mtDNA copy number (Figure 6C).
However, no signiﬁcant eﬀect was observed in the range
of the mtDNA copy number changes in this study on the
cell viability in galactose medium (Figure 6D), while we
did observe a decease in cell viability with the same assay
in cybrids carrying mtDNA from muscle of old mice
(Figure 5C),
These results indicate that the declined mtDNA copy
number might contribute to the compromised respiration
rate and oxidative phosphorylation capacity associated
with the mtDNA from the skeletal muscle of the old
mice. In addition, other age-related mtDNA mutations
Figure 6. mtDNA copy number analysis. (A) Six and 26 months represent 24 and 20 cybrids per age group. Relative mtDNA copy number
(mtDNA/nDNA) was the mtDNA content normalized by nuclear DNA encoded b-actin gene. (B) Relationship between the relative mtDNA
copy number and the maximal respiration as measured by oxygen consumption with uncoupler FCCP in 40 individual transformants of both
age groups. (C) Relationship between the relative mtDNA copy number and the ratio of doubling time (in galactose/in glucose media) in 40
individual transformants of both age groups. (D) Relationship between the relative mtDNA copy number and the ratio of viability (in galactose/
in glucose media). In (B–D), n includes 22 cybrids of 6-month-young mice, and 18 cybrids of 26-month-old mice.
Figure 5. Cell viability analysis. Six and 26 months represent 24 and 25 cybrids per age group, respectively. Cells were grown in glucose-containing
DMEM for 24h, then in glucose medium (A) or in galactose medium (B) for another 72h. Cell viabilities were analyzed with a Vi-cell
TM XR cell
viability analyzer (Beckman Coulter). Three determinations were made for each cybrid. Viability index was calculated as the ratio of percentage of
cell viability in galactose-containing medium to that in glucose medium (C).
Nucleic Acids Research,2010, Vol.38, No. 6 1919in mouse skeletal muscle could also play a role in
age-related pathogenesis.
DISCUSSION
The successful generation of muscle cybrids provided a
unique opportunity to recover and analyze somatic
mtDNA mutations directly from fresh muscle samples.
This new technology also provided an opportunity to
further our ability to investigate diseases or age-related
mtDNA mutations. In addition, since low-occurrence
mutations within the heteroplasmic mtDNA populations
could be enriched in culture cells (24), one great advantage
of this new approach is the potential to study the low level
pathogenic mutations which could otherwise be very dif-
ﬁcult to carry out sophisticated studies on at the molecular
level in tissues.
Studies of the role of mitochondrial dysfunction and
mtDNA mutations in pathogenesis associated with
diseases and aging in skeletal muscle is of particular
interest since: (i) muscle is one of the most targeted
tissues by mitochondrial deﬁciency. Actually, one of the
earliest identiﬁed hallmarks of mitochondrial disease is the
characterization of ragged red ﬁbers (RRG) in biopsied
skeletal muscle, and interestingly most have been
associated with abnormal mtDNA (28). (ii) Skeletal
muscle predominantly relies on oxidative phosphorylation
and at the same time, suﬀers rather marked age-related
degeneration (29). (iii) Skeletal muscle is arguably the
best system where the causative relationship among
age-related degeneration, mitochondrial dysfunction, and
mtDNA alteration, mtDNA deletions in particular, has
been established, owing largely to a collection of excellent
work from Judd Aiken and colleagues (30–34).
Our results revealed that respiration measured with
FCCP was more sensitive in detecting in mitochondrial
function decline associated with aging. The other signiﬁ-
cant result in the present study was the demonstration
that the loss of coupling and regulation of oxidative
phosphorylation associated with mtDNA alteration
during aging. Such an age-related compromise in
coupling eﬃciency of respiration was reported previously
in a large scale investigation with ﬁbroblasts, mostly
skin-derived, from human subjects with a large range
of age, by measurement of P:O ratios (35).
As previously reported with human skeletal muscle (36)
and mitochondrial transformants with mtDNA derived
from human ﬁbroblasts (37), an age-related decline of
mtDNA contents was revealed with mouse skeletal
muscle in this study. However, while we observed the
declines in respiration and growth capacity associated
with the decrease in mtDNA copy number, we did not
see a signiﬁcant correlation between mtDNA content
and cell viability in galactose medium. As shown with
the mutator mice, a premature aging mouse model with
an increase in mtDNA mutations due to the expression of
a proof-reading-deﬁcient version of mtDNA polymerase
(38,39), increased mtDNA mutations have been associated
with enhanced apoptosis. Our results also suggested that
there was an age-related increase in mtDNA mutations
which might also play a role in the decreased viability
in galactose medium associated with the cybrids of
old mice.
As a signiﬁcant diﬀerence between young and old age
groups was only detected when cybrids were grown in
galactose medium, but not in the regular glucose
medium where cells can obtain ATP through both
oxidative phosphorylation and glycolysis, these ﬁndings
suggested that the decrease in mitochondrial ATP produc-
tion in old mitochondria could be compensated for by an
upregulation in the glycolytic pathway. It is interesting to
note that such a bioenergetic switch is also a signature of
cancer cells (40), as aging is the biggest risk factor for
cancer occurrence.
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